Cerebras Systems Inc. (CBRS) falls 10% on AI chip fears
Cerebras Systems Inc. (CBRS) falls sharply as traders react to shifting AI inference expectations and an upcoming share unlock. The move comes despite strong revenue growth and major customer traction, highlighting how valuation and supply concerns can outweigh business progress in a high-beta stock.
Cerebras Systems Inc. (CBRS) fell 10.3% today as investors repriced the stock on concerns that OpenAI and Microsoft may rely more on in-house inference chips, while an October 14 share unlock added near-term supply pressure. The decline reflects sentiment and valuation risk rather than a business breakdown, since Cerebras still shows strong revenue growth and major customer traction. For investors, the selloff underscores that CBRS remains a high-risk, high-expectation AI infrastructure name.
Cerebras Systems Inc. (CBRS) falls 10.32% to $147.22 in regular trading on October 12, 2026, while volume reaches 1.6x its 200-day average. The stock reversed from $164.20 to $146.95 intraday, and 11.0 million shares had traded by the latest update, marking a sharp repricing of a high-beta AI infrastructure story.
Key Takeaways
CBRS falls 10.32% to $147.22, with relative volume at 1.6x the 200-day average.
The strongest catalyst is a negative shift in the OpenAI and Microsoft inference narrative, reinforced by social discussion about in-house AI chips.
An October 14 share unlock adds a near-term supply overhang just two days after the selloff.
Cerebras has strong growth markers, including $210 million in core revenue and $25.4 billion in remaining performance obligations, but its headline EPS remains negative at -$5.14.
Investors should separate business progress from valuation risk. A compelling AI product does not automatically make the stock cheap.
What Is Behind the Cerebras Systems Inc. (CBRS) Selloff Today?
The most likely catalyst is a two-part repricing. First, traders are questioning whether OpenAI and Microsoft will rely as heavily on outside inference infrastructure. Second, shareholders are positioning around Cerebras's October 14 unlock schedule.
The OpenAI narrative has already moved CBRS in both directions. On October 5, Investing.com reported that OpenAI CEO Sam Altman pushed back against speculation that Cerebras had lost a key role in OpenAI's latest model. That episode showed how sensitive the stock is to partnership headlines. provides a concrete precedent for this headline-driven trading pattern.
Today's opposing narrative centers on Microsoft using its own chips for inference. Social discussion is not the same as a company announcement, but it matches the stock's business risk. Cerebras sells specialized speed for AI inference. Any belief that hyperscalers can internalize more of that workload weakens the premium attached to the Cerebras story.
Supply pressure adds force to the move. Cerebras's S-1 lists staged share releases on September 30, October 14, and October 28, with a broader lock-up period ending later. puts the October 14 date directly in front of traders. An upcoming increase in tradable shares can pressure a volatile stock before any holders actually sell.
Cerebras Financials and Valuation After the 10% Drop
The latest quarterly earnings do not show an EPS miss. On August 12, Cerebras reported EPS of -$0.04 against an estimate of -$0.21, an 81.0% positive surprise. However, the broader fundamentals snapshot lists EPS at -$5.14. The contrast matters because investors are valuing a fast-growing company that has not reached sustained profitability.
Cerebras's market capitalization stands at $34.97 billion. Its August business update reported core revenue above $210 million, cloud revenue growth of nearly four times year over year, and $25.4 billion in remaining performance obligations as of June 30, 2026. support a strong growth case, but they also raise the execution bar attached to the stock's valuation.
Jim Cramer described Cerebras as a good company with a stock that was too expensive on October 6. His comment followed trading near $175 on October 7, well above today's $147.22 print. The valuation concern therefore predates this session and helps explain why sentiment reacts quickly to new doubts.
Analyst sentiment remains constructive despite the selloff. Jefferies upgraded CBRS to Outperform on October 5. The analyst consensus lists eight buys and a $300.50 target. That gap between positive long-term ratings and a falling share price signals a market debate over timing, supply, and execution rather than a simple collapse in the business case.
Cerebras AI Chip Positioning and Competitive Pressure
Cerebras is not a standard chip vendor. Its wafer-scale engine places a large computing system on one silicon wafer. The company targets inference, generative AI, and data center workloads that demand high speed and low latency.
The company says its CS-4 system runs up to twice as fast as CS-3 and up to 30 times faster than GPU-based solutions on tokens-per-second-per-user measures. Cerebras also says its architecture avoids some supply constraints tied to HBM memory, CoWoS packaging, and 3nm fabrication.
That differentiation gives CBRS a credible place in the AI infrastructure race. Recent disclosures named OpenAI, AWS, AMD, and CrowdStrike among its partners. On October 7, Gimlet Labs agreed to use Cerebras wafer-scale chips in a disaggregated inference cloud for paying customers.
Still, specialized hardware must win durable workloads against larger GPU ecosystems and internal cloud chips. Cerebras reported 600 megawatts of data center capacity under contract and expected manufacturing capacity to rise more than 10 times in 2026. Those commitments create operating leverage, but they also make customer adoption and delivery execution central to the investment case.
The current evidence favors a narrative shock combined with share-unlock pressure, rather than an earnings failure. The August EPS beat, $210 million core revenue, and $25.4 billion of remaining performance obligations show why investors continue to value Cerebras as a serious AI infrastructure contender.
The risk sits in the price paid for that growth. With negative EPS, a $34.97 billion market capitalization, and a stock trading near its 52-week low of $160.81 before today's decline, CBRS remains a high-risk growth position. A disciplined investor should treat the October 14 unlock and the OpenAI-Microsoft inference debate as separate risks, then judge the stock on customer demand, delivery, and eventual profitability.
CBRS falls sharply because a headline-sensitive AI infrastructure trade now faces both partnership doubts and a near-term share supply event. The business has real growth evidence, but today's volume shows that investors are demanding proof that Cerebras can turn technical speed into durable, profitable scale.
CBRS is falling because traders are reacting to a weaker AI inference narrative around OpenAI and Microsoft, plus an upcoming share unlock that could add supply. The move is amplified by the stock's high valuation and volatility.
+Should I buy CBRS stock now?
CBRS is a speculative buy only for investors who can tolerate sharp swings and valuation risk. The company has strong growth metrics, but the stock still depends on sustained customer demand, execution, and eventual profitability.
+Is this CBRS drop caused by bad earnings?
No, this looks more like a sentiment and supply-driven selloff than an earnings miss. The article says Cerebras recently posted strong growth markers and an EPS beat, but the market is focused on future demand and unlock pressure.
+What does the October 14 share unlock mean for CBRS?
The unlock can increase the number of shares available to trade, which often creates near-term pressure on a volatile stock. Even before holders sell, investors may discount the stock in anticipation of added supply.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on CBRS?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
